FGEN vs RF
FibroGen Inc (FGEN) versus RF (RF) — a side-by-side from cached financials, not a winner call.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
RF (RF) common stock.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
RF does not have a complete income-statement cache yet.
FGEN currently screens at market cap $39.3M. RF currently screens at market cap $0.
Not investment advice. Open the FGEN and RF stock pages for the full models.
Not investment advice.